In vitro evaluation of a series of sympathomimetic amines and the beta-adrenergic blocking properties of cyclopentamine.
D000818:Animals; D003517:Cyclopentanes / Q000494:pharmacology*; D005260:Female; D007082:Ileum / Q000187:drug effects; D066298:In Vitro Techniques; D007545:Isoproterenol / Q000037:antagonists & inhibitors / Q000494:pharmacology; D008680:Metaraminol / Q000494:pharmacology; D008729:Methoxamine / Q000494:pharmacology; D008774:Methylphenidate / Q000494:pharmacology; D009119:Muscle Contraction / Q000187:drug effects*; D009130:Muscle, Smooth / Q000187:drug effects*; D009638:Norepinephrine / Q000494:pharmacology; D010646:Phentolamine / Q000494:pharmacology*; D010656:Phenylephrine / Q000494:pharmacology; D010665:Phenylpropanolamine / Q000494:pharmacology; D011817:Rabbits; D011955:Receptors, Drug; D013565:Sympatholytics / Q000494:pharmacology*; D013566:Sympathomimetics / Q000494:pharmacology*; D013578:Synephrine / Q000494:pharmacology; D014599:Uterus / Q000187:drug effects
D003517:Cyclopentanes; D011955:Receptors, Drug; D013565:Sympatholytics; D013566:Sympathomimetics; D010656:Phenylephrine; D008774:Methylphenidate; D010665:Phenylpropanolamine; D008680:Metaraminol; D008729:Methoxamine; D007545:Isoproterenol; D013578:Synephrine; D009638:Norepinephrine; D010646:Phentolamine